Collectively it appears that an immunological response after vaccination was detected in the majority of vaccines irrespective of the modality of vaccination, confirming earlier conclusions that cancer patients have a residual repertoire of telomerase specific CD8 T cell precursors that can be expanded in vivo by vaccination. This evidence concerns the gene CD8A and cancer.